Actavis Denied Summary Judgment in Testosterone Therapy Case on Warnings Issue

  • Order

CHICAGO — An Illinois federal judge has denied Actavis Inc.’s motion for summary judgment in a testosterone replacement therapy drug case, finding a question of fact as to whether it had a duty under Florida law to provide warnings in a manner apart from the drug’s FDA-approved package insert.

In a Nov. 4 order, Judge Matthew F. Kennelly of the U.S. District Court for the Northern District of Illinois found there “is ample support for the conclusion that Florida courts would reject Actavis’s narrow interpretation of the duty to warn.”

Actavis Inc., Actavis Pharma Inc. and Actavis Laboratories UT Inc. …


HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024 - Salt Lake City, UT
The Grand America Hotel


HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone

June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo